KRAS is mutated in 35–45% of colorectal cancers (CRC), and an additional 5–10% of cases harbor mutations in the NRAS oncogene; alterations in HRAS in CRC are very rare. The gene discussed is NRAS; the disease is colorectal carcinoma.